Symbols / PPCB Stock $0.12 +0.87% Propanc Biopharma, Inc.
PPCB (Stock) Chart
About
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia.
Stock Fundamentals
Scroll to Statements| Market Cap | 2.54M | Enterprise Value | 2.82M | Income | -67.00M | Sales | — | Book/sh | 0.78 | Cash/sh | 0.04 |
| Dividend Yield | — | Payout | 0.00% | Employees | 1 | IPO | — | P/E | 0.00 | Forward P/E | — |
| PEG | — | P/S | — | P/B | 0.15 | P/C | — | EV/EBITDA | -0.04 | EV/Sales | — |
| Quick Ratio | 0.16 | Current Ratio | 2.13 | Debt/Eq | 5.67 | LT Debt/Eq | — | EPS (ttm) | 52.11 | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | -5.36% | ROE | -18.12% | ROIC | — |
| Gross Margin | 0.00% | Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 21.86M | Shs Float | 10.83M | Short Float | 0.96% |
| Short Ratio | 0.07 | Short Interest | — | 52W High | 10.81 | 52W Low | 0.10 | Beta | 3.52 | Avg Volume | 4.13M |
| Volume | 1.84M | Target Price | — | Recom | None | Prev Close | $0.12 | Price | $0.12 | Change | 0.87% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.12
Latest analyst target
3. DCF / Fair value
$11.74
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.12
Low
—
High
—
Mean
—
- [EFFECT] Propanc Biopharma, Inc. SEC Filing - Stock Titan ue, 21 Apr 2026 10
- symbol__ Stock Quote Price and Forecast - CNN Sun, 17 Aug 2025 11
- Propanc Biopharma Inc - Files To Offer Resale Of Up To 15 Million Shares Of Common Stock By Selling Stockholder - SEC Filing - TradingView Fri, 10 Apr 2026 07
- Propanc Biopharma Inc - files to offer resale of up to 15 million shares of common stock by selling stockholder - SEC filing - marketscreener.com Fri, 10 Apr 2026 07
- Experience real-time quotes, in-depth charts, and analyst ratings - webull.com Fri, 15 Aug 2025 15
- Does Propanc Biopharma (NASDAQ:PPCB) Have A Healthy Balance Sheet? - simplywall.st hu, 02 Oct 2025 07
- What should investors watch in Propanc Biopharma (PPCB) Stock | Price at $0.10, Down 3.30% - Risk Reward Ratio - Xã Thanh Hà Sat, 28 Mar 2026 07
- PPCB (PPCB) Stock Price, News & Analysis - MarketBeat Fri, 16 Jan 2026 01
- PPCB Forecast — Price Prediction for 2026. Should I Buy PPCB? - Intellectia AI hu, 22 Jan 2026 23
- Cancer-focused biopharma Propanc plans 2026 human trial, fibrosis work - Stock Titan ue, 13 Jan 2026 08
- PPCB Stock Price and Chart — NASDAQ:PPCB - TradingView hu, 14 Aug 2025 07
- Propanc Biopharma (PPCB) Stock Forecast & Analyst Ratings - Moomoo Sat, 05 Jul 2025 06
- PPCB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI Wed, 01 Apr 2026 10
- Propanc extends 17-year Spain research tie to study aging and cancer - Stock Titan ue, 24 Mar 2026 07
- Propanc Biopharma secures up to $100 million investment from Hexstone By Investing.com - Investing.com Mon, 10 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
57.28
+3628.93%
|
1.54
-13.54%
|
1.78
-10.76%
|
1.99
|
| Research And Development |
|
0.22
-9.83%
|
0.25
+0.07%
|
0.25
-3.18%
|
0.26
|
| Selling General And Administration |
|
57.05
+4329.87%
|
1.29
-15.75%
|
1.53
-11.88%
|
1.73
|
| General And Administrative Expense |
|
57.05
+4329.87%
|
1.29
-15.75%
|
1.53
-11.88%
|
1.73
|
| Other Gand A |
|
57.03
+4448.41%
|
1.25
-16.41%
|
1.50
-12.11%
|
1.71
|
| Total Expenses |
|
57.28
+3628.93%
|
1.54
-13.54%
|
1.78
-10.76%
|
1.99
|
| Operating Income |
|
-57.28
-3628.93%
|
-1.54
+13.54%
|
-1.78
+10.76%
|
-1.99
|
| Total Operating Income As Reported |
|
-57.28
-3628.93%
|
-1.54
+13.54%
|
-1.78
+10.76%
|
-1.99
|
| EBITDA |
|
-58.34
-4522.17%
|
-1.26
+43.52%
|
-2.23
-4.49%
|
-2.14
|
| Normalized EBITDA |
|
-57.26
-3681.07%
|
-1.51
+13.65%
|
-1.75
+11.41%
|
-1.98
|
| Reconciled Depreciation |
|
0.02
-6.78%
|
0.02
-5.56%
|
0.02
+304.36%
|
0.01
|
| EBIT |
|
-58.36
-4445.78%
|
-1.28
+43.13%
|
-2.26
-5.28%
|
-2.14
|
| Total Unusual Items |
|
-1.08
-528.85%
|
0.25
+152.43%
|
-0.48
-202.48%
|
-0.16
|
| Total Unusual Items Excluding Goodwill |
|
-1.08
-528.85%
|
0.25
+152.43%
|
-0.48
-202.48%
|
-0.16
|
| Special Income Charges |
|
-0.87
-1696.32%
|
0.05
+25.53%
|
0.04
+348.35%
|
-0.02
|
| Other Special Charges |
|
0.87
+1696.32%
|
-0.05
-25.53%
|
-0.04
-348.35%
|
0.02
|
| Net Income |
|
-58.92
-3136.60%
|
-1.82
+31.57%
|
-2.66
-0.09%
|
-2.66
|
| Pretax Income |
|
-58.92
-2922.23%
|
-1.95
+30.13%
|
-2.79
-2.85%
|
-2.71
|
| Net Non Operating Interest Income Expense |
|
-0.56
+15.33%
|
-0.67
-24.96%
|
-0.53
+5.40%
|
-0.56
|
| Interest Expense Non Operating |
|
0.56
-15.33%
|
0.67
+24.97%
|
0.53
-6.33%
|
0.57
|
| Net Interest Income |
|
-0.56
+15.33%
|
-0.67
-24.96%
|
-0.53
+5.40%
|
-0.56
|
| Interest Expense |
|
0.56
-15.33%
|
0.67
+24.97%
|
0.53
-6.33%
|
0.57
|
| Interest Income Non Operating |
|
0.00
-85.00%
|
0.00
+66.67%
|
0.00
-99.36%
|
0.01
|
| Interest Income |
|
0.00
-85.00%
|
0.00
+66.67%
|
0.00
-99.36%
|
0.01
|
| Other Income Expense |
|
-1.08
-528.85%
|
0.25
+152.43%
|
-0.48
-202.48%
|
-0.16
|
| Gain On Sale Of Security |
|
-0.21
-206.47%
|
0.20
+137.68%
|
-0.52
-270.62%
|
-0.14
|
| Tax Provision |
|
0.00
+100.00%
|
-0.13
+0.55%
|
-0.13
-136.17%
|
-0.05
|
| Tax Rate For Calcs |
|
0.00
|
0.00
-100.00%
|
0.00
+129.62%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
+100.00%
|
-0.02
-594.59%
|
-0.00
|
| Net Income Including Noncontrolling Interests |
|
-58.92
-3136.60%
|
-1.82
+31.57%
|
-2.66
-0.09%
|
-2.66
|
| Net Income From Continuing Operation Net Minority Interest |
|
-58.92
-3136.60%
|
-1.82
+31.57%
|
-2.66
-0.09%
|
-2.66
|
| Net Income From Continuing And Discontinued Operation |
|
-58.92
-3136.60%
|
-1.82
+31.57%
|
-2.66
-0.09%
|
-2.66
|
| Net Income Continuous Operations |
|
-58.92
-3136.60%
|
-1.82
+31.57%
|
-2.66
-0.09%
|
-2.66
|
| Normalized Income |
|
-57.84
-2690.66%
|
-2.07
+5.87%
|
-2.20
+12.00%
|
-2.50
|
| Net Income Common Stockholders |
|
-58.92
-2826.43%
|
-2.01
+35.61%
|
-3.13
+6.90%
|
-3.36
|
| Otherunder Preferred Stock Dividend |
|
0.00
-100.00%
|
0.19
-58.62%
|
0.47
-33.42%
|
0.70
|
| Diluted EPS |
|
-14.85
+98.95%
|
-1,420.53
+95.46%
|
-31,268.39
+97.21%
|
-1,119,475.67
|
| Basic EPS |
|
-14.85
+98.95%
|
-1,420.53
+95.46%
|
-31,268.39
+97.21%
|
-1,119,475.67
|
| Basic Average Shares |
|
3.97
+279940.65%
|
0.00
+1317.00%
|
0.00
+3233.33%
|
0.00
|
| Diluted Average Shares |
|
3.97
+279940.65%
|
0.00
+1317.00%
|
0.00
+3233.33%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-58.92
-2826.43%
|
-2.01
+35.61%
|
-3.13
+6.90%
|
-3.36
|
| Rent And Landing Fees |
|
0.03
-22.23%
|
0.03
+18.41%
|
0.03
+1.67%
|
0.03
|
| Rent Expense Supplemental |
|
0.03
-22.23%
|
0.03
+18.41%
|
0.03
+1.67%
|
0.03
|
| Line Item | Trend | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Total Assets |
|
0.07
+19.95%
|
0.06
-26.11%
|
0.08
|
—
|
| Current Assets |
|
0.03
+33.63%
|
0.02
+26.67%
|
0.02
|
—
|
| Cash Cash Equivalents And Short Term Investments |
|
0.02
+109.86%
|
0.01
+147.04%
|
0.00
|
—
|
| Cash And Cash Equivalents |
|
0.02
+109.86%
|
0.01
+147.04%
|
0.00
|
—
|
| Cash Financial |
|
0.02
+109.86%
|
0.01
+147.04%
|
0.00
|
—
|
| Receivables |
|
0.00
+2.90%
|
0.00
+22.42%
|
0.00
|
—
|
| Taxes Receivable |
|
0.00
+2.90%
|
0.00
+22.42%
|
0.00
|
—
|
| Prepaid Assets |
|
0.00
-100.00%
|
0.01
-28.95%
|
0.01
|
—
|
| Other Current Assets |
|
0.00
-77.04%
|
0.01
-28.95%
|
0.01
|
—
|
| Total Non Current Assets |
|
0.05
+13.65%
|
0.04
-38.02%
|
0.07
|
—
|
| Net PPE |
|
0.02
-54.70%
|
0.04
-39.13%
|
0.06
|
—
|
| Gross PPE |
|
0.09
+0.12%
|
0.09
-3.37%
|
0.09
|
—
|
| Accumulated Depreciation |
|
-0.07
-41.27%
|
-0.05
-72.87%
|
-0.03
|
—
|
| Properties |
|
0.00
|
0.00
|
0.00
|
—
|
| Buildings And Improvements |
|
0.07
+0.00%
|
0.07
+0.00%
|
0.07
|
—
|
| Machinery Furniture Equipment |
|
0.03
+0.44%
|
0.03
-11.15%
|
0.03
|
—
|
| Non Current Deferred Assets |
|
0.03
|
0.00
|
—
|
—
|
| Non Current Prepaid Assets |
|
0.00
+0.45%
|
0.00
-3.66%
|
0.00
|
—
|
| Total Liabilities Net Minority Interest |
|
3.85
+21.21%
|
3.18
+2.33%
|
3.11
|
—
|
| Current Liabilities |
|
3.79
+20.09%
|
3.16
+3.11%
|
3.06
|
—
|
| Payables And Accrued Expenses |
|
2.13
+31.41%
|
1.62
+8.22%
|
1.50
|
—
|
| Payables |
|
1.24
+24.77%
|
1.00
+2.32%
|
0.97
|
—
|
| Accounts Payable |
|
1.21
+25.51%
|
0.97
+2.51%
|
0.94
|
—
|
| Current Accrued Expenses |
|
0.89
+42.02%
|
0.62
+19.18%
|
0.52
|
—
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.64
+8.81%
|
0.59
+41.32%
|
0.42
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.89
+68.93%
|
0.53
-47.24%
|
1.00
|
—
|
| Current Debt |
|
0.87
+72.28%
|
0.51
-48.33%
|
0.98
|
—
|
| Other Current Borrowings |
|
0.67
+31.76%
|
0.51
-48.33%
|
0.98
|
—
|
| Current Capital Lease Obligation |
|
0.02
-9.97%
|
0.02
+4.37%
|
0.02
|
—
|
| Other Current Liabilities |
|
0.13
-68.36%
|
0.42
+179.79%
|
0.15
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.06
+204.19%
|
0.02
-54.45%
|
0.04
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
0.06
+204.19%
|
0.02
-54.45%
|
0.04
|
—
|
| Long Term Debt |
|
0.06
|
—
|
—
|
—
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.02
-54.45%
|
0.04
|
—
|
| Stockholders Equity |
|
-3.78
-21.23%
|
-3.12
-3.09%
|
-3.02
|
—
|
| Common Stock Equity |
|
-3.78
-21.23%
|
-3.12
-2.92%
|
-3.03
|
—
|
| Capital Stock |
|
0.00
-99.90%
|
0.01
+46.03%
|
0.01
|
—
|
| Common Stock |
|
0.00
-99.90%
|
0.01
+3088.33%
|
0.00
|
—
|
| Preferred Stock |
|
0.00
|
0.00
-100.00%
|
0.01
|
—
|
| Share Issued |
|
0.01
+7880.00%
|
0.00
+3233.33%
|
0.00
|
—
|
| Ordinary Shares Number |
|
0.01
+7880.00%
|
0.00
+3233.33%
|
0.00
|
—
|
| Treasury Shares Number |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Additional Paid In Capital |
|
61.70
+2.30%
|
60.31
+5.14%
|
57.36
|
—
|
| Retained Earnings |
|
-66.70
-3.11%
|
-64.68
-5.08%
|
-61.56
|
—
|
| Gains Losses Not Affecting Retained Earnings |
|
1.27
-1.95%
|
1.29
+4.89%
|
1.23
|
—
|
| Treasury Stock |
|
0.05
+0.00%
|
0.05
+0.00%
|
0.05
|
—
|
| Other Equity Adjustments |
|
1.27
-1.95%
|
1.29
+4.89%
|
1.23
|
—
|
| Total Equity Gross Minority Interest |
|
-3.78
-21.23%
|
-3.12
-3.09%
|
-3.02
|
—
|
| Total Capitalization |
|
-3.72
-19.35%
|
-3.12
-3.09%
|
-3.02
|
—
|
| Working Capital |
|
-3.77
-20.01%
|
-3.14
-2.99%
|
-3.05
|
—
|
| Invested Capital |
|
-2.85
-9.12%
|
-2.61
-27.35%
|
-2.05
|
—
|
| Total Debt |
|
0.95
+73.70%
|
0.55
-47.53%
|
1.04
|
—
|
| Net Debt |
|
0.91
+83.37%
|
0.50
-49.15%
|
0.97
|
—
|
| Capital Lease Obligations |
|
0.02
-52.52%
|
0.04
-35.19%
|
0.06
|
—
|
| Net Tangible Assets |
|
-3.78
-21.23%
|
-3.12
-3.09%
|
-3.02
|
—
|
| Tangible Book Value |
|
-3.78
-21.23%
|
-3.12
-2.92%
|
-3.03
|
—
|
| Current Notes Payable |
|
0.20
|
0.00
|
—
|
—
|
| Dueto Related Parties Current |
|
0.03
+0.44%
|
0.03
-3.63%
|
0.03
|
—
|
| Interest Payable |
|
0.09
+111.62%
|
0.04
-22.68%
|
0.06
|
—
|
| Other Equity Interest |
|
—
|
—
|
-0.02
|
—
|
| Preferred Shares Number |
|
—
|
—
|
0.50
+0.00%
|
0.50
|
| Preferred Stock Equity |
|
—
|
—
|
0.01
+0.00%
|
0.01
|
| Line Item | Trend | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-0.41
+56.67%
|
-0.94
+15.39%
|
-1.11
+23.05%
|
-1.44
|
| Cash Flow From Continuing Operating Activities |
|
-0.41
+56.67%
|
-0.94
+15.39%
|
-1.11
+23.05%
|
-1.44
|
| Net Income From Continuing Operations |
|
-58.92
-3136.60%
|
-1.82
+31.57%
|
-2.66
-0.09%
|
-2.66
|
| Depreciation Amortization Depletion |
|
0.02
-6.78%
|
0.02
-5.56%
|
0.02
+304.36%
|
0.01
|
| Depreciation |
|
0.02
-6.78%
|
0.02
-5.56%
|
0.02
+304.36%
|
0.01
|
| Depreciation And Amortization |
|
0.02
-6.78%
|
0.02
-5.56%
|
0.02
+304.36%
|
0.01
|
| Other Non Cash Items |
|
51.66
+17244.08%
|
0.30
-8.71%
|
0.33
-10.58%
|
0.36
|
| Stock Based Compensation |
|
4.62
|
0.00
|
—
|
—
|
| Provisionand Write Offof Assets |
|
0.00
-100.00%
|
0.12
|
0.00
|
—
|
| Operating Gains Losses |
|
1.08
+3826.59%
|
0.03
-96.25%
|
0.73
+7.27%
|
0.68
|
| Gain Loss On Investment Securities |
|
0.12
+16.28%
|
0.10
-86.39%
|
0.77
+22.68%
|
0.62
|
| Net Foreign Currency Exchange Gain Loss |
|
0.09
+504.18%
|
-0.02
-275.19%
|
-0.01
-113.88%
|
0.04
|
| Change In Working Capital |
|
1.14
+172.68%
|
0.42
-11.67%
|
0.47
+182.25%
|
0.17
|
| Change In Receivables |
|
-0.00
-3287.32%
|
-0.00
+88.36%
|
-0.00
-136.75%
|
0.00
|
| Change In Prepaid Assets |
|
0.00
+101.19%
|
-0.12
-5425.94%
|
0.00
+125.31%
|
-0.01
|
| Change In Payables And Accrued Expense |
|
1.12
+111.03%
|
0.53
+74.73%
|
0.30
+105.71%
|
0.15
|
| Change In Accrued Expense |
|
0.93
+223.19%
|
0.29
+29.47%
|
0.22
+73.00%
|
0.13
|
| Change In Payable |
|
0.19
-22.56%
|
0.24
+199.36%
|
0.08
+329.12%
|
0.02
|
| Change In Account Payable |
|
0.19
-22.56%
|
0.24
+199.36%
|
0.08
+329.12%
|
0.02
|
| Change In Other Working Capital |
|
0.04
+66.08%
|
0.02
-87.05%
|
0.19
+524.98%
|
0.03
|
| Change In Other Current Liabilities |
|
-0.02
-0.57%
|
-0.02
-8.77%
|
-0.02
-505.95%
|
-0.00
|
| Financing Cash Flow |
|
0.49
-47.90%
|
0.94
-15.43%
|
1.11
-25.29%
|
1.49
|
| Cash Flow From Continuing Financing Activities |
|
0.49
-47.90%
|
0.94
-15.43%
|
1.11
-25.29%
|
1.49
|
| Net Issuance Payments Of Debt |
|
0.76
-17.79%
|
0.92
+55.67%
|
0.59
-22.99%
|
0.77
|
| Issuance Of Debt |
|
0.89
-16.53%
|
1.06
+79.88%
|
0.59
-22.99%
|
0.77
|
| Repayment Of Debt |
|
-0.13
+8.48%
|
-0.14
|
0.00
|
0.00
|
| Long Term Debt Issuance |
|
0.34
+12.80%
|
0.30
|
0.00
-100.00%
|
0.77
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
0.34
+12.80%
|
0.30
|
0.00
-100.00%
|
0.77
|
| Short Term Debt Issuance |
|
0.54
-28.34%
|
0.76
+28.26%
|
0.59
-22.99%
|
0.77
|
| Short Term Debt Payments |
|
-0.13
+8.48%
|
-0.14
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
0.41
-32.96%
|
0.61
+4.05%
|
0.59
-22.99%
|
0.77
|
| Net Common Stock Issuance |
|
0.00
-100.00%
|
0.02
-6.69%
|
0.02
-75.11%
|
0.10
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
-100.00%
|
0.47
-24.00%
|
0.63
|
| Net Other Financing Charges |
|
-0.26
|
—
|
0.02
|
—
|
| Changes In Cash |
|
0.09
+1163.11%
|
0.01
-19.98%
|
0.01
-84.46%
|
0.05
|
| Effect Of Exchange Rate Changes |
|
-0.09
-2319.26%
|
0.00
+271.30%
|
-0.00
+95.28%
|
-0.05
|
| Beginning Cash Position |
|
0.02
+109.86%
|
0.01
+147.04%
|
0.00
+80.35%
|
0.00
|
| End Cash Position |
|
0.01
-42.67%
|
0.02
+109.86%
|
0.01
+147.04%
|
0.00
|
| Free Cash Flow |
|
-0.41
+56.67%
|
-0.94
+15.39%
|
-1.11
+23.05%
|
-1.44
|
| Interest Paid Supplemental Data |
|
0.03
+223.62%
|
0.01
+229.21%
|
0.00
+20.53%
|
0.00
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Amortization Of Securities |
|
—
|
—
|
—
|
0.45
|
| Change In Interest Payable |
|
0.26
+224.08%
|
0.08
-14.86%
|
0.09
+44.77%
|
0.06
|
| Common Stock Issuance |
|
0.00
-100.00%
|
0.02
-6.69%
|
0.02
-75.11%
|
0.10
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
0.02
-6.69%
|
0.02
-75.11%
|
0.10
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-02-26 View
- 10-Q2026-02-17 View
- 8-K2026-01-07 View
- 10-Q2025-11-14 View
- 8-K2025-11-10 View
- 8-K2025-10-14 View
- 10-K2025-09-29 View
- 8-K2025-08-19 View
- 8-K2025-08-13 View
- 8-K2025-07-30 View
- 8-K2025-07-22 View
- 8-K2025-06-27 View
- 8-K2025-06-18 View
- 8-K2025-06-02 View
- 10-Q2025-05-15 View
- 8-K2025-05-08 View
- 8-K2025-04-21 View
- 8-K2025-03-18 View
- 10-Q2025-02-14 View
- 8-K2025-02-12 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|